What's in Thinq Pharma-CRO Pte. Ltd.'s pipeline?

Thinq Pharma-CRO Pte. Ltd. has 2 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Thinq Pharma-CRO Pte. Ltd.'s portfolio?

Top competitors by shared drug class: , Alexza Pharmaceuticals, Inc., Alza Corporation, DE, USA, Assistance Publique Hopitaux De Marseille, Eli Lilly and Company.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/thinq-pharma-cro-pte-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Thinq Pharma-CRO Pte. Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Thinq Pharma-CRO Pte. Ltd. pipeline: 0 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Roxane Laboratories Inc., USA	Roxane Laboratories Inc., USA	phase 3	Central nervous system stimulant		Attention deficit hyperactivity disorder
Unique Pharmaceutical Laboratories, India	Unique Pharmaceutical Laboratories, India	phase 3

Therapeutic area mix

Attention deficit hyperactivity disorder · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

· 1 shared drug class
Alexza Pharmaceuticals, Inc. · 1 shared drug class
Alza Corporation, DE, USA · 1 shared drug class
Assistance Publique Hopitaux De Marseille · 1 shared drug class
Eli Lilly and Company · 1 shared drug class
Impax Laboratories, LLC · 1 shared drug class
Janssen-Cilag International NV · 1 shared drug class
McMaster University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Thinq Pharma-CRO Pte. Ltd.:

Cite this brief

Drug Landscape (2026). Thinq Pharma-CRO Pte. Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/thinq-pharma-cro-pte-ltd. Accessed 2026-05-17.